share_log

Sight Sciences Up 21%, Insider Buyers Are Up 147%

Sight Sciences Up 21%, Insider Buyers Are Up 147%

Sight Sciences股價上漲21%,內部買家增加了147%。
Simply Wall St ·  07/12 08:43

Sight Sciences, Inc. (NASDAQ:SGHT) insiders who purchased shares in the last 12 months were richly rewarded last week. The stock climbed by 21% resulting in a US$66m addition to the company's market value. In other words, the original US$2.99m purchase is now worth US$7.41m.

過去12個月內,Sight Sciences, Inc.(NASDAQ:SGHT)內部人員購買的股票獲得了豐厚的回報。該股上漲21%,導致公司市值增加了6600萬美元。換句話說,原始的299萬美元的購買現在價值741萬元美元。

While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we do think it is perfectly logical to keep tabs on what insiders are doing.

雖然我們絕不建議投資者僅基於公司董事所做的事情來作出決策,但我們認爲密切關注內部人士所做的事情是完全合理的。

Sight Sciences Insider Transactions Over The Last Year

過去一年中的 Sight Sciences 內部交易

In the last twelve months, the biggest single purchase by an insider was when Independent Chairman Staffan Encrantz bought US$1.8m worth of shares at a price of US$3.46 per share. We do like to see buying, but this purchase was made at well below the current price of US$7.52. While it does suggest insiders consider the stock undervalued at lower prices, this transaction doesn't tell us much about what they think of current prices.

過去12個月內,獨立董事長Staffan Encrantz的最大單筆購買是以每股3.46美元的價格購買了價值180萬美元的股票。我們確實喜歡看到購買,但此次交易的價格遠低於當前的7.52美元。雖然這表明內部人士認爲該股在較低價格時被低估,但此次交易並沒有告訴我們他們對當前價格的看法。

Staffan Encrantz purchased 985.12k shares over the year. The average price per share was US$3.04. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. By clicking on the graph below, you can see the precise details of each insider transaction!

Staffan Encrantz在一年內購買了985,120股,平均每股價格爲3.04美元。您可以在下面的圖表中查看公司和個人過去一年的內部交易。點擊下面的圖表,您可以看到每個內部交易的詳細信息!

big
NasdaqGS:SGHT Insider Trading Volume July 12th 2024
NasdaqGS:SGHt Insider Trading Volume 2024年7月12日

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of undervalued small cap companies that insiders are buying.

還有很多其他的公司,公司的內部人士正在購買股票。你可能不想錯過這個免費的小市值公司的低估列表。

Sight Sciences Insiders Are Selling The Stock

Sight Sciences 內部人士正在賣出股票

Over the last three months, we've seen significant insider selling at Sight Sciences. In total, insiders dumped US$290k worth of shares in that time, and we didn't record any purchases whatsoever. Overall this makes us a bit cautious, but it's not the be all and end all.

過去三個月,我們看到在 Sight Sciences 進行了大量內部人員銷售。在那個時候,總計內部人員拋售了29萬美元的股票,而我們沒有記錄到任何購買。總體而言,這使我們有點謹慎,但這並不是一切的終止。

Insider Ownership Of Sight Sciences

Sight Sciences 內部持股

Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. I reckon it's a good sign if insiders own a significant number of shares in the company. It appears that Sight Sciences insiders own 21% of the company, worth about US$66m. This level of insider ownership is good but just short of being particularly stand-out. It certainly does suggest a reasonable degree of alignment.

測試一個公司領導者與其他股東之間的一致性的另一種方法是看他們擁有多少股份。如果內部人員擁有公司中相當數量的股份,則這是一個好跡象。看起來 Sight Sciences 內部人員擁有公司的21%,價值約爲6600萬美元。這種內部持股水平不錯,但還不足以特別出色。它確實表明了相當程度的一致性。

So What Does This Data Suggest About Sight Sciences Insiders?

Sight Sciences 內部人員交易的數據表明了什麼?

Insiders sold Sight Sciences shares recently, but they didn't buy any. In contrast, they appear keener if you look at the last twelve months. And insiders do own shares. So we're not overly bothered by recent selling. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. You'd be interested to know, that we found 4 warning signs for Sight Sciences and we suggest you have a look.

內部人員最近出售了 Sight Sciences 股票,但他們沒有買入任何股票。相反,如果您看過去的一年,他們似乎更熱衷於購買。內部人員確實擁有股份。因此,我們對最近的出售並不過分擔心。因此,這些內部交易可以幫助我們建立對該股票的投資信仰,但也值得了解該公司面臨的風險。你會很感興趣知道,我們發現 Sight Sciences 存在4個預警信號,建議您查看。

Of course Sight Sciences may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

當然,Sight Sciences 可能不是最好的股票購買選擇。因此,您可能希望查看這些高質量公司的免費收藏。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

對於本文而言,內部人是指向相關監管機構報告其交易的個人。我們目前僅考慮公開市場交易和直接利益的私人處置,但不包括衍生交易或間接利益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?關注內容?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

對本文有反饋? 對內容感到擔憂? 請直接與我們聯繫。 或者,發送電子郵件至editorial-team@simplywallst.com。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論